L’avis intitulé « Vaccin antigrippal EFLUELDA : transition du vaccin antigrippal EFLUELDA, de sa forme quadrivalente à une forme trivalente, dans la stratégie de vaccination contre la grippe saisonnière », ci-joint, est adopté.
Voir aussi
Recommandation vaccinale
13/02/2025
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
T8rVfEYpBnLwt1VB
